Pursuing Specific Chemotherapy of Orthotopic Breast Cancer with Lung Metastasis from Docking Nanoparticles Driven by Bioinspired Exosomes
0303 health sciences
Lung Neoplasms
Breast Neoplasms
Serum Albumin, Human
Exosomes
3. Good health
Mice
03 medical and health sciences
Drug Delivery Systems
RAW 264.7 Cells
Animals
Humans
Nanoparticles
Female
Prodrugs
Laurates
Platinum
DOI:
10.1021/acs.nanolett.9b00824
Publication Date:
2019-04-09T21:04:53Z
AUTHORS (9)
ABSTRACT
Breast cancer develops from local tissue but is characterized by a distinct metastatic pattern involving regional lymph nodes and distant organs, which the primary cause of high mortality in breast patients. Herein, optimal docking nanoparticles (NPs) composed laurate-functionalized Pt(IV) prodrug (Pt(lau)), human serum albumin (HSA), lecithin were predicted computational modeling, prepared nanoprecipitation, validated fluorescence spectroscopy. As macrophages have been reported to be preferentially recruited cancer, Rex, exosome spontaneously secreted murine RAW 264.7 cells, was isolated encapsulate NPs. This high-performance delivery system, called NPs/Rex, possessed desired physicochemical properties, enhanced colloidal stability, redox-triggered release profile. Investigations cytodynamics proved that NPs/Rex internalized through multiple pathways, avoided entrapment bilayers, successfully platinized nucleic acids after bioreduction cytosol. Intracellular activation Pt(lau) confirmed observing characteristic effects cisplatin on cell proliferation cycle following treatment with NPs/Rex. During vivo application, bioinspired Rex coating endowed NPs prolonged blood circulation, smart organ tropism, biocompatibility, as well robust platinum (Pt) chemotherapy for cells orthotopic tumors fat pads nodules lungs. Therefore, this favorable nanoplatform might provide valuable insight into derivatization development Pt anticancer drugs used currently clinic.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (62)
CITATIONS (92)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....